Watch this company for free updates
Simply enter your email address below and we will send you an email when the company files any documents or there is a change to their credit report.
We require your email address in order to send you alerts by email. You can unsubscribe at any time.
Thank you, you are now watching this company.
You will receive email updates when this company's information changes.
You can choose which alerts you receive and can unsubscribe at any time.
Unlock F2G LTD's Credit Report?
Unlock The Full Report
- Credit score, financials and risk data
- Directors, shareholders and ownership
- CCJs, payment behaviour and filing history
- 5 official Companies House documents
- Instant download and online viewing
- Email alerts for key changes
- Personal monitoring dashboard
Upgrade to Lite
- 5 credit reports
- 100 accounts downloads
- 100 accounts exports
Your plan will start immediately and the time remaining on your existing plan will be refunded
Yes, upgrade to LiteF2G LTD
LAB B, GROUND FLOOR BLOCK 50, ALDERLEY PARK, MACCLESFIELD, CHESHIRE, SK10 4TG
Buy Report - £20
Download PDF
Unlock the Full Company Report
- ✓ Check whether this company is legitimate
- ✓ See if this company is likely to run into financial trouble
- ✓ Find out who owns and runs the company
- ✓ Avoid risky business relationships
- ✓ Get instant updates if anything important changes
- ✓ Access official company documents for free
F2G LTD
Private limited with Share Capital
Active - Accounts Filed
10 June 1998
72110 Research and experimental development on biotechnology - Research and experimental development on biotechnology
Available to 02 Oct 2025. Next accounts due by 30 Sep 2026
Is F2G LTD in debt to you?
Don't write it off. As exclusively featured on Can't Pay? We'll Take It Away!, DCBL provides a nationwide service recovering over £85 million annually.
Our unique "One Solution" works seamlessly with DCB Legal, managing debt recovery from the first letter through to High Court enforcement.
We act fast to protect your cash flow and recover what you're owed. Recover your debt with the UK's experts.
Current Directors & Secretaries
For a full in-depth analysis on each of these directors, click any of the links below
| Name | Role | Date Of Birth | Appointed |
|---|---|---|---|
| Mr Henry Bradford Skinner | Director | ||
| Mr Tobias George Sykes | Director | ||
| Dr Nanna Liebach Luneborg | Director | ||
| Dr Joseph Anderson | Director | ||
| Dr Sylvie Louise Gregoire | Director | ||
| Ms Camilla Soenderby | Director | ||
| Mr Francesco Maria Lavino | Director | ||
| Dr William Henry Lewarne West | Director | ||
| Mr Naveed Siddiqi | Director | ||
| Mr Timothy Anderson | Director | ||
| Dr Patrick Volkert Jozef Johannes Vink | Director | ||
| Mr Kaasim Mahmood | Director | ||
| Dr Michael Birch | Company Secretary | ||
| Ms Suzanne Lynne Powell | Company Secretary |
Previous Directors & Secretaries
Mortgages and Charges
Total Outstanding
3
Total Satisfied
6
| Type | Created | Registered | Persons Entitled | Status |
|---|---|---|---|---|
| European Investment Bank | OUTSTANDING | |||
| European Investment Bank | OUTSTANDING | |||
| Debenture | K/s Bi Biomedical Venture Annex Iii Merifin Capital N.v. K Nominees Limited And Astellas Ventur | SATISFIED | ||
| Rent Deposit Deed | Akcros Chemicals Limited | OUTSTANDING | ||
| Debenture | K/s Bi Biomedical Venture Annex Iii, Merifin Capital N.v, K Nominees Limited(The Lenders) | SATISFIED | ||
| Rent Deposit Deed | Akcros Chemicals Limited | SATISFIED | ||
| Debenture | P/s Bi Biomedicinsk Venture Iii, Merifin Capital N.v. And K Nominees | SATISFIED | ||
| Debenture | P/s Bi Biomedicinsk Venture Iii, Merifin Capital N.v. And K Nominees Limited | SATISFIED | ||
| Debenture | Hsbc Bank PLC | SATISFIED |
Key Financials
| Accounts | |||||
|---|---|---|---|---|---|
| Cash | £73,281,330.00 | £50,457,366.00 | £98,851,438.00 | £7,818,662.00 | £23,531,929.00 |
| Net Worth | -£7,086,847.00 | -£13,207,922.00 | £28,675,917.00 | -£42,703,248.00 | -£18,787,882.00 |
| Total Current Liabilities | £6,789,649.00 | £6,871,047.00 | £14,657,540.00 | £12,135,789.00 | £6,381,802.00 |
| Total Current Assets | £82,668,814.00 | £59,328,038.00 | £102,240,402.00 | £13,785,208.00 | £27,951,609.00 |
Frequently Asked Questions about F2G LTD
Detailed answers about F2G LTD, including incorporation, status, business activity, and accounts information.
When was F2G LTD founded?
F2G LTD was officially incorporated on 10 June 1998 and is registered under company number 03578625. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is F2G LTD?
Private limited with Share Capital. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. For example, a private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of F2G LTD?
F2G LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does F2G LTD do?
F2G LTD operates in the following sector: 72110 Research and experimental development on biotechnology - Research and experimental development on biotechnology . This provides insight into the company’s primary business activities and industry focus. Knowing the SIC code and description is useful for market research, assessing competitors, and understanding potential business risks.
What is F2G LTD's registered address?
The registered office address of F2G LTD is Alderley Park, Macclesfield, Cheshire East, SK10 4TG. This is the official address filed with Companies House for legal and statutory correspondence.
Is F2G LTD financially stable?
Based on the latest accounts up to 02 Oct 2025, F2G LTD has filed financial statements showing its assets, liabilities, and overall trading performance. The next accounts are due by 30 Sep 2026. Reviewing these accounts helps assess the company’s financial stability, creditworthiness, and risk profile, which is crucial for investors, suppliers, and potential business partners.